1 of 12

975

Eligible patients

Excluded:

5 patients with X

10 patients with Y

10 patients without Z

Pour éviter les problèmes:

Lignes verticales = flèches « droites »

Lignes horizontales = flèches « coudées »

2 of 12

Excluded:

10 patients with missing data on X

1000

Patients aged 18-80 years

alive on January 1, 2022

975

Eligible patients

Excluded:

5 patients with X

10 patients with Y

10 patients without Z

965

Patients included at baseline

Excluded from longitudinal analyses:

100 patients lost from follow-up

100 patients died

765

Patients included in�longitudinal analyses

3 of 12

Excluded:

10 patients with missing data on X

1000

Patients aged 18-80 years

alive on January 1, 2022

975

Eligible patients

Excluded:

5 patients with X

10 patients with Y

10 patients without Z

965

Patients included at baseline

Excluded from longitudinal analyses:

100 patients lost from follow-up

100 patients died

765

Patients included in�longitudinal analyses

4 of 12

Excluded:

10 patients with missing data on X

1000

Patients aged 18-80 years

alive on January 1, 2022

975

Eligible patients

Excluded:

5 patients with X

10 patients with Y

10 patients without Z

965

Patients included at baseline

Excluded from longitudinal analyses:

100 patients lost from follow-up

100 patients died

765

Patients included in�longitudinal analyses

5 of 12

Excluded:

10 patients with missing data on X

1000

Patients aged 18-80 years

alive on January 1, 2022

975

Eligible patients

Excluded:

5 patients with X

10 patients with Y

10 patients without Z

965

Patients included at baseline

Excluded from longitudinal analyses:

100 patients lost from follow-up

100 patients died

765

Patients included in�longitudinal analyses

6 of 12

3500 Individuals (≥18 years) living in city Z

on 1 January 2015

3450 Individuals were potentially eligible

3410 Individuals were included in the analysis

50 Did not meet the eligibility criteria

10 Reason 1

20 Reason 2

20 Reason 3

40 Excluded from the analysis

40 Reason for exclusion

1136 With variable X = 1

1137 With variable X = 2

1137 With variable X = 3

7 of 12

3500 Individuals (≥18 years) living in city Z

on 1 January 2015

3450 Individuals were potentially eligible

3410 Individuals were included in the analysis

50 Did not meet the eligibility criteria

10 Reason 1

20 Reason 2

20 Reason 3

40 Excluded from the analysis

40 Reason for exclusion

1136 With variable X = 1

1137 With variable X = 2

1137 With variable X = 3

8 of 12

3500 Individuals (≥18 years) living in city Z

on 1 January 2015

3450 Individuals were potentially eligible

3410 Individuals were included in the analysis

50 Did not meet the eligibility criteria

10 Reason 1

20 Reason 2

20 Reason 3

40 Excluded from the analysis

40 Reason for exclusion

N= 1705�Intervention group

N= 1705�Control group

9 of 12

3500 Individuals (≥18 years) living in city Z

on 1 January 2015

3450 Individuals were potentially eligible

3410 Individuals were included in the analysis

50 Did not meet the eligibility criteria

10 Reason 1

20 Reason 2

20 Reason 3

40 Excluded from the analysis

40 Reason for exclusion

N= 1705�Intervention group

N= 1705�Control group

10 of 12

3500 Individuals (≥18 years) living in city Z

on 1 January 2015

3450 Individuals were potentially eligible

3410 Individuals were included in the analysis

50 Did not meet the eligibility criteria

10 Reason 1

20 Reason 2

20 Reason 3

40 Excluded from the analysis

40 Reason for exclusion

N= 1705�Intervention group

N= 1705�Control group

11 of 12

100 Patients assessed for eligibility

50 Randomized

50 Excluded

10 Did not meet inclusion criteria

20 Declined to participate

20 Other reasons…

N= 25�Allocated to treatment A

N= 25�Allocated to treatment B

N= 23�Received treatment A

N= 24�Received reatment B

N= 22 with follow-up data

(1 lost to follow-up)

N= 22 with follow-up data

(2 lost to follow-up)

12 of 12

100 Patients assessed for eligibility

50 Randomized

50 Excluded

10 Did not meet inclusion criteria

20 Declined to participate

20 Other reasons…

N= 25�Allocated to treatment A

N= 25�Allocated to treatment B

N= 23�Received treatment A

N= 24�Received reatment B

N= 22 with follow-up data

(1 lost to follow-up)

N= 22 with follow-up data

(2 lost to follow-up)